Megakaryocyte markers in myeloproliferative disorders
Related Experiment Videos
12nd Department of Medicine, University Medical School, Debrecen, Hungary.
Abstract:
Identification of megakaryocyte precursors with immunohistochemical methods in bone marrow trephine biopsy specimens (embedded in a plastic resin, Immuno-Bed) was performed from patients with blastic phase of chronic granulocytic leukaemia (five cases), from chronic megakaryocytic-granulocytic myelosis (four cases) and from acute megakaryoblastic leukaemia (11 cases). In megakaryoblasts of bone marrow biopsies immunohistochemical reactions using the ABC method and monoclonal antibodies against von Willebrand antigen and GpIIb/IIIa (CD41) were visible in various percentages depending on the maturation's degree of megakaryocyte precursors. The number of circulating blast cells determined by flow cytophotometry was nearly similar to those of observed in biopsies. The greatest bone marrow reticulin content could be detected in acute megakaryoblastic leukaemia cases. Despite the different clinicopathological entities, the presence of the same phenotype (megakaryoblasts) was associated with a short survival in these haematological malignancies (in CGL MKB phase 4.0, in CMGM MKB phase 4.2, and in AML M7 5.8 months, respectively).
Insights
Immunohistochemistry identified megakaryoblasts in various leukemia types. This megakaryoblast phenotype, regardless of the specific leukemia, correlated with poor patient survival in these hematologic malignancies.
Area of Science:
- Hematology
- Oncology
- Immunohistochemistry
Background:
- Megakaryocyte precursors are crucial in hematopoiesis.
- Identifying megakaryoblasts aids in diagnosing and classifying myeloid malignancies.
- Previous methods for identifying megakaryoblasts had limitations.
Purpose of the Study:
- To identify megakaryocyte precursors using immunohistochemical methods.
- To correlate the presence of megakaryoblasts with patient survival across different hematologic malignancies.
- To compare blast cell counts in peripheral blood and bone marrow.
Main Methods:
- Bone marrow trephine biopsy specimens were processed using plastic resin embedding (Immuno-Bed).
- Immunohistochemical staining was performed using the ABC method with monoclonal antibodies against von Willebrand antigen and GpIIb/IIIa (CD41).
- Flow cytometry was used to determine circulating blast cell counts.
Main Results:
- Immunohistochemical reactions for megakaryoblasts were observed with varying intensity based on precursor maturation.
- Circulating blast cell counts by flow cytometry closely matched bone marrow biopsy findings.
- Acute megakaryoblastic leukemia cases exhibited the highest bone marrow reticulin content.
- The presence of megakaryoblasts, irrespective of the specific clinicopathological entity, was associated with significantly shorter patient survival.
Conclusions:
- Immunohistochemistry is effective for identifying megakaryocyte precursors in bone marrow biopsies.
- The megakaryoblast phenotype is a significant prognostic indicator for poor survival in chronic granulocytic leukemia, chronic megakaryocytic-granulocytic myelosis, and acute megakaryoblastic leukemia.
- Further research into the specific mechanisms driving poor prognosis in megakaryoblast-positive leukemias is warranted.